nodes	percent_of_prediction	percent_of_DWPC	metapath
Pindolol—Ocular discomfort—Methotrexate—colon cancer	0.0326	0.0336	CcSEcCtD
Pindolol—Peripheral coldness—Capecitabine—colon cancer	0.0209	0.0215	CcSEcCtD
Pindolol—Heartburn—Fluorouracil—colon cancer	0.0206	0.0213	CcSEcCtD
Pindolol—Keratitis—Capecitabine—colon cancer	0.0153	0.0158	CcSEcCtD
Pindolol—Psoriasis—Methotrexate—colon cancer	0.0118	0.0122	CcSEcCtD
Pindolol—Visual disturbance—Irinotecan—colon cancer	0.0114	0.0117	CcSEcCtD
Pindolol—Cardiac failure—Fluorouracil—colon cancer	0.0106	0.0109	CcSEcCtD
Pindolol—Lethargy—Fluorouracil—colon cancer	0.0105	0.0109	CcSEcCtD
Pindolol—Orthostatic hypotension—Irinotecan—colon cancer	0.00983	0.0102	CcSEcCtD
Pindolol—Cramp muscle—Irinotecan—colon cancer	0.0097	0.01	CcSEcCtD
Pindolol—Erectile dysfunction—Vincristine—colon cancer	0.0088	0.00909	CcSEcCtD
Pindolol—Nadolol—ABCB1—colon cancer	0.00872	0.27	CrCbGaD
Pindolol—Depression—Vincristine—colon cancer	0.0085	0.00878	CcSEcCtD
Pindolol—Sleep disorder—Capecitabine—colon cancer	0.00833	0.0086	CcSEcCtD
Pindolol—Sweating—Vincristine—colon cancer	0.00817	0.00844	CcSEcCtD
Pindolol—Sweating—Irinotecan—colon cancer	0.00796	0.00822	CcSEcCtD
Pindolol—Conjunctivitis—Fluorouracil—colon cancer	0.00773	0.00798	CcSEcCtD
Pindolol—Hot flush—Capecitabine—colon cancer	0.0077	0.00796	CcSEcCtD
Pindolol—Menopausal symptoms—Capecitabine—colon cancer	0.00764	0.00789	CcSEcCtD
Pindolol—Hallucination—Vincristine—colon cancer	0.00761	0.00786	CcSEcCtD
Pindolol—Atenolol—ABCB1—colon cancer	0.00761	0.236	CrCbGaD
Pindolol—Bradycardia—Irinotecan—colon cancer	0.00758	0.00784	CcSEcCtD
Pindolol—Cardiac failure—Capecitabine—colon cancer	0.00738	0.00763	CcSEcCtD
Pindolol—Lethargy—Capecitabine—colon cancer	0.00735	0.0076	CcSEcCtD
Pindolol—Visual impairment—Irinotecan—colon cancer	0.00718	0.00742	CcSEcCtD
Pindolol—Cardiac disorder—Vincristine—colon cancer	0.0071	0.00734	CcSEcCtD
Pindolol—Acebutolol—ABCB1—colon cancer	0.00702	0.218	CrCbGaD
Pindolol—Angiopathy—Vincristine—colon cancer	0.00694	0.00717	CcSEcCtD
Pindolol—Cardiac disorder—Irinotecan—colon cancer	0.00691	0.00714	CcSEcCtD
Pindolol—Mediastinal disorder—Vincristine—colon cancer	0.00689	0.00712	CcSEcCtD
Pindolol—Angiopathy—Irinotecan—colon cancer	0.00676	0.00698	CcSEcCtD
Pindolol—Mediastinal disorder—Irinotecan—colon cancer	0.00671	0.00694	CcSEcCtD
Pindolol—Mental disorder—Vincristine—colon cancer	0.0067	0.00692	CcSEcCtD
Pindolol—Orthostatic hypotension—Capecitabine—colon cancer	0.00658	0.0068	CcSEcCtD
Pindolol—Flatulence—Irinotecan—colon cancer	0.00639	0.0066	CcSEcCtD
Pindolol—Muscle spasms—Irinotecan—colon cancer	0.00623	0.00644	CcSEcCtD
Pindolol—Bronchospasm—Capecitabine—colon cancer	0.00613	0.00633	CcSEcCtD
Pindolol—Vertigo—Vincristine—colon cancer	0.00598	0.00618	CcSEcCtD
Pindolol—Abdominal discomfort—Capecitabine—colon cancer	0.00597	0.00617	CcSEcCtD
Pindolol—Metoprolol—ABCB1—colon cancer	0.00593	0.184	CrCbGaD
Pindolol—Vertigo—Irinotecan—colon cancer	0.00583	0.00602	CcSEcCtD
Pindolol—Syncope—Irinotecan—colon cancer	0.00582	0.00601	CcSEcCtD
Pindolol—Loss of consciousness—Irinotecan—colon cancer	0.0057	0.00589	CcSEcCtD
Pindolol—Myalgia—Vincristine—colon cancer	0.00567	0.00586	CcSEcCtD
Pindolol—Weight increased—Capecitabine—colon cancer	0.00567	0.00586	CcSEcCtD
Pindolol—Visual disturbance—Methotrexate—colon cancer	0.00566	0.00585	CcSEcCtD
Pindolol—Depression—Capecitabine—colon cancer	0.00554	0.00572	CcSEcCtD
Pindolol—Lethargy—Methotrexate—colon cancer	0.00547	0.00566	CcSEcCtD
Pindolol—Oedema—Vincristine—colon cancer	0.00543	0.00562	CcSEcCtD
Pindolol—Conjunctivitis—Capecitabine—colon cancer	0.0054	0.00558	CcSEcCtD
Pindolol—Confusional state—Irinotecan—colon cancer	0.00534	0.00551	CcSEcCtD
Pindolol—Nervous system disorder—Vincristine—colon cancer	0.00533	0.00551	CcSEcCtD
Pindolol—Oedema—Irinotecan—colon cancer	0.00529	0.00547	CcSEcCtD
Pindolol—Myalgia—Fluorouracil—colon cancer	0.00529	0.00546	CcSEcCtD
Pindolol—Chest pain—Fluorouracil—colon cancer	0.00529	0.00546	CcSEcCtD
Pindolol—Hyperhidrosis—Vincristine—colon cancer	0.00525	0.00543	CcSEcCtD
Pindolol—Shock—Irinotecan—colon cancer	0.00521	0.00538	CcSEcCtD
Pindolol—Nervous system disorder—Irinotecan—colon cancer	0.00519	0.00536	CcSEcCtD
Pindolol—Hyperhidrosis—Irinotecan—colon cancer	0.00512	0.00529	CcSEcCtD
Pindolol—Confusional state—Fluorouracil—colon cancer	0.00511	0.00528	CcSEcCtD
Pindolol—Hypotension—Vincristine—colon cancer	0.00508	0.00525	CcSEcCtD
Pindolol—Bradycardia—Capecitabine—colon cancer	0.00508	0.00524	CcSEcCtD
Pindolol—Oedema—Fluorouracil—colon cancer	0.00507	0.00524	CcSEcCtD
Pindolol—Nervous system disorder—Fluorouracil—colon cancer	0.00497	0.00514	CcSEcCtD
Pindolol—Musculoskeletal discomfort—Vincristine—colon cancer	0.00495	0.00512	CcSEcCtD
Pindolol—Tachycardia—Fluorouracil—colon cancer	0.00495	0.00511	CcSEcCtD
Pindolol—Hypotension—Irinotecan—colon cancer	0.00495	0.00511	CcSEcCtD
Pindolol—Insomnia—Vincristine—colon cancer	0.00492	0.00508	CcSEcCtD
Pindolol—Paraesthesia—Vincristine—colon cancer	0.00488	0.00504	CcSEcCtD
Pindolol—Visual impairment—Capecitabine—colon cancer	0.0048	0.00496	CcSEcCtD
Pindolol—Insomnia—Irinotecan—colon cancer	0.00479	0.00495	CcSEcCtD
Pindolol—Paraesthesia—Irinotecan—colon cancer	0.00475	0.00491	CcSEcCtD
Pindolol—Hypotension—Fluorouracil—colon cancer	0.00474	0.00489	CcSEcCtD
Pindolol—Dyspnoea—Irinotecan—colon cancer	0.00472	0.00488	CcSEcCtD
Pindolol—Somnolence—Irinotecan—colon cancer	0.0047	0.00486	CcSEcCtD
Pindolol—Gastrointestinal disorder—Vincristine—colon cancer	0.00469	0.00485	CcSEcCtD
Pindolol—Fatigue—Vincristine—colon cancer	0.00469	0.00484	CcSEcCtD
Pindolol—Dyspepsia—Irinotecan—colon cancer	0.00466	0.00481	CcSEcCtD
Pindolol—Tinnitus—Capecitabine—colon cancer	0.00465	0.0048	CcSEcCtD
Pindolol—Pain—Vincristine—colon cancer	0.00465	0.0048	CcSEcCtD
Pindolol—Constipation—Vincristine—colon cancer	0.00465	0.0048	CcSEcCtD
Pindolol—Cardiac disorder—Capecitabine—colon cancer	0.00463	0.00478	CcSEcCtD
Pindolol—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.00462	0.00477	CcSEcCtD
Pindolol—Insomnia—Fluorouracil—colon cancer	0.00458	0.00474	CcSEcCtD
Pindolol—Gastrointestinal disorder—Irinotecan—colon cancer	0.00457	0.00472	CcSEcCtD
Pindolol—Fatigue—Irinotecan—colon cancer	0.00456	0.00471	CcSEcCtD
Pindolol—Paraesthesia—Fluorouracil—colon cancer	0.00455	0.0047	CcSEcCtD
Pindolol—Pain—Irinotecan—colon cancer	0.00453	0.00468	CcSEcCtD
Pindolol—Constipation—Irinotecan—colon cancer	0.00453	0.00468	CcSEcCtD
Pindolol—Angiopathy—Capecitabine—colon cancer	0.00452	0.00467	CcSEcCtD
Pindolol—Dyspnoea—Fluorouracil—colon cancer	0.00452	0.00467	CcSEcCtD
Pindolol—Somnolence—Fluorouracil—colon cancer	0.00451	0.00466	CcSEcCtD
Pindolol—Mediastinal disorder—Capecitabine—colon cancer	0.00449	0.00464	CcSEcCtD
Pindolol—Dyspepsia—Fluorouracil—colon cancer	0.00446	0.00461	CcSEcCtD
Pindolol—Abdominal discomfort—Methotrexate—colon cancer	0.00445	0.00459	CcSEcCtD
Pindolol—Gastrointestinal pain—Vincristine—colon cancer	0.00444	0.00459	CcSEcCtD
Pindolol—Gastrointestinal disorder—Fluorouracil—colon cancer	0.00438	0.00452	CcSEcCtD
Pindolol—Mental disorder—Capecitabine—colon cancer	0.00437	0.00451	CcSEcCtD
Pindolol—Feeling abnormal—Irinotecan—colon cancer	0.00436	0.00451	CcSEcCtD
Pindolol—Pain—Fluorouracil—colon cancer	0.00433	0.00448	CcSEcCtD
Pindolol—Gastrointestinal pain—Irinotecan—colon cancer	0.00433	0.00447	CcSEcCtD
Pindolol—Abdominal pain—Vincristine—colon cancer	0.0043	0.00444	CcSEcCtD
Pindolol—Flatulence—Capecitabine—colon cancer	0.00428	0.00442	CcSEcCtD
Pindolol—Erectile dysfunction—Methotrexate—colon cancer	0.00427	0.00441	CcSEcCtD
Pindolol—Abdominal pain—Irinotecan—colon cancer	0.00418	0.00432	CcSEcCtD
Pindolol—Feeling abnormal—Fluorouracil—colon cancer	0.00418	0.00432	CcSEcCtD
Pindolol—Muscle spasms—Capecitabine—colon cancer	0.00417	0.00431	CcSEcCtD
Pindolol—Drowsiness—Methotrexate—colon cancer	0.00413	0.00427	CcSEcCtD
Pindolol—Depression—Methotrexate—colon cancer	0.00412	0.00426	CcSEcCtD
Pindolol—Tremor—Capecitabine—colon cancer	0.00407	0.0042	CcSEcCtD
Pindolol—Conjunctivitis—Methotrexate—colon cancer	0.00402	0.00415	CcSEcCtD
Pindolol—Sweating—Methotrexate—colon cancer	0.00396	0.0041	CcSEcCtD
Pindolol—Vertigo—Capecitabine—colon cancer	0.0039	0.00403	CcSEcCtD
Pindolol—Asthenia—Vincristine—colon cancer	0.0039	0.00403	CcSEcCtD
Pindolol—Syncope—Capecitabine—colon cancer	0.00389	0.00402	CcSEcCtD
Pindolol—Palpitations—Capecitabine—colon cancer	0.00384	0.00396	CcSEcCtD
Pindolol—Loss of consciousness—Capecitabine—colon cancer	0.00381	0.00394	CcSEcCtD
Pindolol—Asthenia—Irinotecan—colon cancer	0.0038	0.00392	CcSEcCtD
Pindolol—Diarrhoea—Vincristine—colon cancer	0.00372	0.00384	CcSEcCtD
Pindolol—Myalgia—Capecitabine—colon cancer	0.00369	0.00382	CcSEcCtD
Pindolol—Chest pain—Capecitabine—colon cancer	0.00369	0.00382	CcSEcCtD
Pindolol—Arthralgia—Capecitabine—colon cancer	0.00369	0.00382	CcSEcCtD
Pindolol—Anxiety—Capecitabine—colon cancer	0.00368	0.0038	CcSEcCtD
Pindolol—Diarrhoea—Irinotecan—colon cancer	0.00362	0.00374	CcSEcCtD
Pindolol—Dry mouth—Capecitabine—colon cancer	0.00361	0.00373	CcSEcCtD
Pindolol—Dizziness—Vincristine—colon cancer	0.00359	0.00371	CcSEcCtD
Pindolol—Pruritus—Fluorouracil—colon cancer	0.00359	0.00371	CcSEcCtD
Pindolol—Visual impairment—Methotrexate—colon cancer	0.00358	0.0037	CcSEcCtD
Pindolol—Confusional state—Capecitabine—colon cancer	0.00357	0.00369	CcSEcCtD
Pindolol—Oedema—Capecitabine—colon cancer	0.00354	0.00366	CcSEcCtD
Pindolol—Dizziness—Irinotecan—colon cancer	0.0035	0.00362	CcSEcCtD
Pindolol—Shock—Capecitabine—colon cancer	0.00348	0.0036	CcSEcCtD
Pindolol—Nervous system disorder—Capecitabine—colon cancer	0.00347	0.00359	CcSEcCtD
Pindolol—Diarrhoea—Fluorouracil—colon cancer	0.00347	0.00358	CcSEcCtD
Pindolol—Tinnitus—Methotrexate—colon cancer	0.00346	0.00358	CcSEcCtD
Pindolol—Tachycardia—Capecitabine—colon cancer	0.00346	0.00357	CcSEcCtD
Pindolol—Vomiting—Vincristine—colon cancer	0.00346	0.00357	CcSEcCtD
Pindolol—Cardiac disorder—Methotrexate—colon cancer	0.00344	0.00356	CcSEcCtD
Pindolol—Rash—Vincristine—colon cancer	0.00343	0.00354	CcSEcCtD
Pindolol—Hyperhidrosis—Capecitabine—colon cancer	0.00342	0.00354	CcSEcCtD
Pindolol—Dermatitis—Vincristine—colon cancer	0.00342	0.00354	CcSEcCtD
Pindolol—Headache—Vincristine—colon cancer	0.0034	0.00352	CcSEcCtD
Pindolol—Angiopathy—Methotrexate—colon cancer	0.00337	0.00348	CcSEcCtD
Pindolol—Vomiting—Irinotecan—colon cancer	0.00336	0.00348	CcSEcCtD
Pindolol—Dizziness—Fluorouracil—colon cancer	0.00335	0.00346	CcSEcCtD
Pindolol—Mediastinal disorder—Methotrexate—colon cancer	0.00334	0.00346	CcSEcCtD
Pindolol—Rash—Irinotecan—colon cancer	0.00334	0.00345	CcSEcCtD
Pindolol—Dermatitis—Irinotecan—colon cancer	0.00333	0.00344	CcSEcCtD
Pindolol—Headache—Irinotecan—colon cancer	0.00332	0.00343	CcSEcCtD
Pindolol—Hypotension—Capecitabine—colon cancer	0.00331	0.00342	CcSEcCtD
Pindolol—Mental disorder—Methotrexate—colon cancer	0.00325	0.00336	CcSEcCtD
Pindolol—Nausea—Vincristine—colon cancer	0.00323	0.00334	CcSEcCtD
Pindolol—Musculoskeletal discomfort—Capecitabine—colon cancer	0.00323	0.00333	CcSEcCtD
Pindolol—Vomiting—Fluorouracil—colon cancer	0.00322	0.00333	CcSEcCtD
Pindolol—Insomnia—Capecitabine—colon cancer	0.0032	0.00331	CcSEcCtD
Pindolol—Rash—Fluorouracil—colon cancer	0.0032	0.0033	CcSEcCtD
Pindolol—Dermatitis—Fluorouracil—colon cancer	0.00319	0.0033	CcSEcCtD
Pindolol—Paraesthesia—Capecitabine—colon cancer	0.00318	0.00329	CcSEcCtD
Pindolol—Headache—Fluorouracil—colon cancer	0.00318	0.00328	CcSEcCtD
Pindolol—Dyspnoea—Capecitabine—colon cancer	0.00316	0.00326	CcSEcCtD
Pindolol—Nausea—Irinotecan—colon cancer	0.00314	0.00325	CcSEcCtD
Pindolol—Dyspepsia—Capecitabine—colon cancer	0.00312	0.00322	CcSEcCtD
Pindolol—Gastrointestinal disorder—Capecitabine—colon cancer	0.00306	0.00316	CcSEcCtD
Pindolol—Fatigue—Capecitabine—colon cancer	0.00305	0.00316	CcSEcCtD
Pindolol—Pain—Capecitabine—colon cancer	0.00303	0.00313	CcSEcCtD
Pindolol—Constipation—Capecitabine—colon cancer	0.00303	0.00313	CcSEcCtD
Pindolol—Nausea—Fluorouracil—colon cancer	0.00301	0.00311	CcSEcCtD
Pindolol—Propranolol—ABCB1—colon cancer	0.00299	0.0927	CrCbGaD
Pindolol—Feeling abnormal—Capecitabine—colon cancer	0.00292	0.00302	CcSEcCtD
Pindolol—Vertigo—Methotrexate—colon cancer	0.0029	0.003	CcSEcCtD
Pindolol—Gastrointestinal pain—Capecitabine—colon cancer	0.0029	0.00299	CcSEcCtD
Pindolol—Abdominal pain—Capecitabine—colon cancer	0.0028	0.00289	CcSEcCtD
Pindolol—Myalgia—Methotrexate—colon cancer	0.00275	0.00284	CcSEcCtD
Pindolol—Chest pain—Methotrexate—colon cancer	0.00275	0.00284	CcSEcCtD
Pindolol—Arthralgia—Methotrexate—colon cancer	0.00275	0.00284	CcSEcCtD
Pindolol—Confusional state—Methotrexate—colon cancer	0.00266	0.00275	CcSEcCtD
Pindolol—Nervous system disorder—Methotrexate—colon cancer	0.00259	0.00267	CcSEcCtD
Pindolol—Hyperhidrosis—Methotrexate—colon cancer	0.00255	0.00263	CcSEcCtD
Pindolol—Asthenia—Capecitabine—colon cancer	0.00254	0.00263	CcSEcCtD
Pindolol—Pruritus—Capecitabine—colon cancer	0.00251	0.00259	CcSEcCtD
Pindolol—Hypotension—Methotrexate—colon cancer	0.00246	0.00255	CcSEcCtD
Pindolol—Diarrhoea—Capecitabine—colon cancer	0.00242	0.0025	CcSEcCtD
Pindolol—Musculoskeletal discomfort—Methotrexate—colon cancer	0.0024	0.00248	CcSEcCtD
Pindolol—Insomnia—Methotrexate—colon cancer	0.00238	0.00246	CcSEcCtD
Pindolol—Paraesthesia—Methotrexate—colon cancer	0.00237	0.00245	CcSEcCtD
Pindolol—Dyspnoea—Methotrexate—colon cancer	0.00235	0.00243	CcSEcCtD
Pindolol—Somnolence—Methotrexate—colon cancer	0.00234	0.00242	CcSEcCtD
Pindolol—Dizziness—Capecitabine—colon cancer	0.00234	0.00242	CcSEcCtD
Pindolol—Dyspepsia—Methotrexate—colon cancer	0.00232	0.0024	CcSEcCtD
Pindolol—Gastrointestinal disorder—Methotrexate—colon cancer	0.00228	0.00235	CcSEcCtD
Pindolol—Fatigue—Methotrexate—colon cancer	0.00227	0.00235	CcSEcCtD
Pindolol—Pain—Methotrexate—colon cancer	0.00225	0.00233	CcSEcCtD
Pindolol—Vomiting—Capecitabine—colon cancer	0.00225	0.00233	CcSEcCtD
Pindolol—Rash—Capecitabine—colon cancer	0.00223	0.00231	CcSEcCtD
Pindolol—Dermatitis—Capecitabine—colon cancer	0.00223	0.00231	CcSEcCtD
Pindolol—Headache—Capecitabine—colon cancer	0.00222	0.00229	CcSEcCtD
Pindolol—Feeling abnormal—Methotrexate—colon cancer	0.00217	0.00225	CcSEcCtD
Pindolol—Gastrointestinal pain—Methotrexate—colon cancer	0.00216	0.00223	CcSEcCtD
Pindolol—Nausea—Capecitabine—colon cancer	0.0021	0.00217	CcSEcCtD
Pindolol—Abdominal pain—Methotrexate—colon cancer	0.00208	0.00215	CcSEcCtD
Pindolol—Asthenia—Methotrexate—colon cancer	0.00189	0.00195	CcSEcCtD
Pindolol—Pruritus—Methotrexate—colon cancer	0.00187	0.00193	CcSEcCtD
Pindolol—Diarrhoea—Methotrexate—colon cancer	0.0018	0.00186	CcSEcCtD
Pindolol—Dizziness—Methotrexate—colon cancer	0.00174	0.0018	CcSEcCtD
Pindolol—Vomiting—Methotrexate—colon cancer	0.00168	0.00173	CcSEcCtD
Pindolol—Rash—Methotrexate—colon cancer	0.00166	0.00172	CcSEcCtD
Pindolol—Dermatitis—Methotrexate—colon cancer	0.00166	0.00172	CcSEcCtD
Pindolol—Headache—Methotrexate—colon cancer	0.00165	0.00171	CcSEcCtD
Pindolol—Nausea—Methotrexate—colon cancer	0.00157	0.00162	CcSEcCtD
